亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer

作者
Xiaoyue Liu,Tianhao Zhou,Yongmei Wang,Min Pei,Guifeng Wang,Wendi Chu,Qi Wang,Shaoqian Du,Hongxia Wang,Chunhe Wang
出处
期刊:OncoTargets and Therapy [Dove Medical Press]
卷期号:Volume 15: 509-520 被引量:16
标识
DOI:10.2147/ott.s354048
摘要

Purpose: Trophoblast cell surface antigen 2 (TROP2) has emerged as a promising target of antibody-drug conjugates (ADCs) for triple-negative breast cancer (TNBC), as well as other breast cancers (BCs). This study aims to investigate the biomarker value of TROP2 for patient-tailoring and prognostic for BC patients, including TNBC. Methods: The levels of TROP2 expression in 404 Chinese BC tissues on tissue microarrays (TMAs) were quantified by immunohistochemistry and their correlations to the clinicopathological factors and the overall survival rate were analyzed. Also, BC cell lines and patient-derived organoids (PDOs) with different TROP2 expression levels were employed to investigate the correlation between TROP2 expression levels and the therapeutic responses to DS001, a TROP2-directed ADC molecule with stable linker and potent payload. Results: TROP2 overexpression was identified in significantly more ( P = 0.046) tumor tissues (41.08%, 99/241) than normal adjacent tissues (31.29%, 51/163) from Chinese BC patients, and in significantly more ( P = 0.024) TNBC patients (59.38%, 19/32) than in other BC types (38.28%, 80/209). BC cell line with the lowest TROP2 expression level failed to respond to DS001 treatment. The levels of TROP2 expression were determined to be significantly correlated with the potencies of DS001 treatment, but not with the overall survival rates of the patients. Conclusion: Our results demonstrated that TROP2 could serve as a patient-tailoring and predictive biomarker for ADC therapeutics but not as a general prognostic biomarker to predicate patient survival. Keywords: TROP2, breast cancer, triple-negative breast cancer, antibody–drug conjugate, biomarker

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lhw发布了新的文献求助10
1秒前
xiaoguoxiaoguo完成签到,获得积分10
4秒前
ycq发布了新的文献求助30
5秒前
沧海君完成签到,获得积分10
6秒前
完美世界的应助被啊啊啊啊采纳,获得10
8秒前
留胡子的鸿涛完成签到,获得积分10
14秒前
fantasy的应助被小峰采纳,获得10
15秒前
17秒前
谁将新樽乘旧月完成签到,获得积分10
18秒前
ppp发布了新的文献求助10
22秒前
branyez完成签到,获得积分10
22秒前
啊啊啊啊发布了新的文献求助10
23秒前
23秒前
啊啊啊啊完成签到,获得积分10
31秒前
文艺的老姆完成签到,获得积分10
34秒前
怡然冰颜完成签到 ,获得积分10
40秒前
49秒前
葱葱完成签到,获得积分10
50秒前
哈哈哈哈完成签到,获得积分10
50秒前
宁静致远完成签到 ,获得积分10
53秒前
丘比特的应助被康子浩采纳,获得10
57秒前
59秒前
59秒前
59秒前
cc完成签到 ,获得积分10
1分钟前
ppp发布了新的文献求助10
1分钟前
1分钟前
粗心的丹萱完成签到,获得积分10
1分钟前
粗犷的颜完成签到,获得积分10
1分钟前
康子浩发布了新的文献求助10
1分钟前
1分钟前
王艳发布了新的文献求助10
1分钟前
zsp完成签到,获得积分10
1分钟前
感存算完成签到,获得积分10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
1分钟前
FashionBoy的应助被科研通管家采纳,获得10
1分钟前
SciGPT的应助被英俊大树采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165939
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749898
捐赠科研通 7756692
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553385
邀请新用户注册赠送积分活动 2473623